The prevalence and antifungal susceptibility profile of Candida dubliniensis and Candida albicans in the respiratory tract of patients with cystic fibrosis
Microbiology Spectrum · 2025
DOI: 10.1128/spectrum.01907-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Emily Krantz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Clinical Nutrition, Institution of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Cystic Fibrosis, Antifungal Agents, Candida, Candida albicans. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Respiratory infections are the leading cause of mortality and morbidity among cystic fibrosis (CF) patients. Pathogenic bacteria and fungi such as Pseudomonas aeruginosa , Staphylococcus aureus , and various yeasts as well as filamentous fungi are commonly identified opportunistic microorganisms recovered in the sputa from CF patients. The clinical significance of yeasts, particularly Candida species, in patients with CF is not fully understood. Furthermore, the emergence of antifungal resistance in clinical settings is a global concern. This study aimed to determine the prevalence of Candida species with special focus on Candida dubliniensis and Candida albicans in sputum samples from patients with CF and evaluate their susceptibility to antifungal agents. A total of 968 culture-positive sputum samples were collected from 193 patients with CF over a period of 1 year. Fungal isolates were identified to the species level using matrix-assisted laser desorption ionization-time-of-flight mass spectrometry. The antifungal susceptibility of Candida isolates was determined using Sensititre YeastOne panels. The most commonly isolated yeast species in these sputum samples were C. dubliniensis (13%) and C. albicans (32%). Colonization with C. dubliniensis or C. albicans was not associated with a deteriorated lung function. Voriconazole had the lowest minimum inhibitory concentration (MIC) against C. dubliniensis and C. albicans . Itraconazole showed higher MIC values to Candida albicans . An increased understanding of the antifungal susceptibility profiles of Candida species isolated from CF patients may provide valuable knowledge about treatment of yeast infections in this patient group. IMPORTANCE Our findings indicate that colonization with Candida dubliniensis and Candida albicans does not exert a significant impact on pulmonary function in individuals with cystic fibrosis. Furthermore, antifungal resistance among the isolated Candida species was generally low.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine and Clinical Nutrition, Institution of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Gothenburg CF-Centre, Department of Respiratory Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Clinical Microbiology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Gothenburg CF-Centre, Department of Pediatrics, Queen Silvia Children's Hospital, Gothenburg, Sweden.
ORCID-Profile: Emily Krantz, Nahid Kondori
Zitieren
APA
Krantz, E., Jönsson, B., Gilljam, M., Lindblad, A., Abedzadeh, B., Karlsson, R., & Kondori, N. (2025). The prevalence and antifungal susceptibility profile of Candida dubliniensis and Candida albicans in the respiratory tract of patients with cystic fibrosis. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01907-25
Vancouver
Krantz E, Jönsson B, Gilljam M, Lindblad A, Abedzadeh B, Karlsson R, et al. The prevalence and antifungal susceptibility profile of Candida dubliniensis and Candida albicans in the respiratory tract of patients with cystic fibrosis. Microbiology Spectrum. 2025. doi:10.1128/spectrum.01907-25
BibTeX
@article{Krantz2025,
author = {Krantz, Emily and Jönsson, Bodil and Gilljam, Marita and Lindblad, Anders and Abedzadeh, Bahman and Karlsson, Roger and Kondori, Nahid},
title = {The prevalence and antifungal susceptibility profile of Candida dubliniensis and Candida albicans in the respiratory tract of patients with cystic fibrosis},
journal = {Microbiology Spectrum},
year = {2025},
doi = {10.1128/spectrum.01907-25}
}
EUVIMED